TICKER CODE: JAGX
Company Name: JAGUAR HEALTH, INC
US Stocks Health Technology Pharmaceuticals: Generic
Position Proposed: BUY
BUY ENTRY: NOW READY (1.90-2.40)
1st Partial Take Profit: 5.45 (in 2 Months 2021)
2nd Partial Take Profit: 8.25 (Aug-Sept 2021)
3rd Partial Take Profit: 12.70 (End 2021)
Expected Take Profit: 17.15 (Early - Mid 2022)
Potential Take Profit: 29.50 (End 2022)
NOTE THAT THE TIMELINE IS ONLY AN ESTIMATION
Stop Loss: 1.40
Technical Analysis
1. LARGE INVERTED HEAD & SHOULDERS PATTERN (PARTIALLY COMPLETE)
2. Small Falling Wedge Completed
3. Fibonacci Retracement at 0.786
4. 1st Partial Take Profit is at Fibonacci Extension Level 1 Grey Zone (Safe Zone) which is also at the price range of the pole.
5. 2nd Partial Take Profit will complete the head formation of a smaller INVERTED HEAD & SHOULDERS
it will also hit key horizontal structure levels which will very likely create a short consolidation
Company Name: JAGUAR HEALTH, INC
US Stocks Health Technology Pharmaceuticals: Generic
Position Proposed: BUY
BUY ENTRY: NOW READY (1.90-2.40)
1st Partial Take Profit: 5.45 (in 2 Months 2021)
2nd Partial Take Profit: 8.25 (Aug-Sept 2021)
3rd Partial Take Profit: 12.70 (End 2021)
Expected Take Profit: 17.15 (Early - Mid 2022)
Potential Take Profit: 29.50 (End 2022)
NOTE THAT THE TIMELINE IS ONLY AN ESTIMATION
Stop Loss: 1.40
Technical Analysis
1. LARGE INVERTED HEAD & SHOULDERS PATTERN (PARTIALLY COMPLETE)
2. Small Falling Wedge Completed
3. Fibonacci Retracement at 0.786
4. 1st Partial Take Profit is at Fibonacci Extension Level 1 Grey Zone (Safe Zone) which is also at the price range of the pole.
5. 2nd Partial Take Profit will complete the head formation of a smaller INVERTED HEAD & SHOULDERS
it will also hit key horizontal structure levels which will very likely create a short consolidation
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.